19. E. Goldberg, The New Executive Brain: Frontal Lobes in a Complex World (New York: Oxford University Press, 2009).

20. H. L. Campbell, M. E. Tivarus, A. Hillier, and D. Q. Beversdorf, «Increased Task Difficulty Results in Greater Impact of Noradrenergic Modulation of Cognitive Flexibility», Pharmacology, Biochemistry and Behavior 88 (2008): 222–229; S. F. Smyth and D. Q. Beversdorf, «Lack of Dopaminergic Modulation of Cognitive Flexibility», Cognitive and Behavioral Neurology 20 (2007): 225–229; D. Q. Beversdorf, J. D. Hughes, B. A. Lewis, and K. M. Heilman, «Noradrenergic Modulation of Cognitive Flexibility in Problem Solving», Neuroreport 10 (1999): 2763–2767.

21. U. Kischka, T. Kammer, S. Maier, M. Weisbrod, M. Thimm, and M. Spitzer, «Dopaminergic Modulation of Semantic Network Activation», Neuropsychologia 34 (1996): 1107–1113; J. S. Cios, R. F. Miller, A. Hiller, M. E. Tivarus, and D. Q. Beversdorf, «Lack of Noradrenergic Modulation of Indirect Semantic Priming», Behavioral Neurology 21 (2009): 137–143.

22. T. W. Robbins, «Shifting and Stopping: Fronto-striatal Substrates, Neurochemical Modulation and Clinical Implications», Philosophical Transactions of the Royal Society of London, B: Biological Sciences 362 (2007): 917–932; D. Q. Beversdorf, «Pharmacological Effects on Creativity», in Neuroscience of Creativity, Eds. O. Vartanian, A. S. Bristol, and J. C. Kaufman (Cambridge, MA: MIT Press, 2013): 151–173.

23. H. Takeuchi, Y. Taki, Y. Sassa, H. Hashizume, A. Sekiguchi, A. Fukushima, and R. Kawashima, «Regional Gray Matter Volume of Dopaminergic System Associate with Creativity: Evidence from Voxel-based Morphometry», Neuroimage 51 (2010): 578–585.

24. C. R. Cloninger, D. M. Svrakic, and T. R. Przybeck, «A Psychobiological Model of Temperament and Character», Archives of General Psychiatry 50 (1993): 975–990.

25. I. Greese and S. D. Iversen, «The Role of Forebrain Dopamine Systems in Amphetamine Induced Stereotyped Behavior in the Rat», Psychopharmacologia 39 (1974): 345–357; J. J. Canales and A. M. Graybiel, «A Measure of Striatal Function Predicts Motor Stereotypy», Nature Neuroscience 3 (2000): 377–383; E. Saka, C. Goodrich, P. Harlan, B. K. Madras, and A. M. Graybiel, «Repetitive Behaviors in Monkeys Are Linked to Specific Striatal Activation Patterns», Journal of Neuroscience 24 (2004): 7557–7565; O. De Manzano, S. Cervenka, A. Karabanov, L. Farde, and F. Ullén, «Thinking Outside a Less Intact Box: Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals», PLoS One 17 (2010): E10670.

26. K. A. Zalocusky, C. Ramakrishnan, T. N. Lerner, T. J. Davidson, B. Knutson, and K. Deisseroth, «Nucleus Accumbens D2R Cells Signal Prior Outcomes and Control Risky Decision-Making», Nature 531 (2016): 642–646.

27. V. D. Costa, V. L. Tran, J. Turchi, and B. B. Averbeck, «Dopamine Modulates Novelty Seeking Behavior During Decision Making», Behavioral Neuroscience 128 (2014): 556–566.

28. R. M. Bilder, J. Volavka, H. M. Lachman, and A. A. Grace, «The Catechol-OMethyltransferase Polymorphism: Relations to the Tonic— Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes», Neuropsychopharmacology 29 (2004): 1943–1961.

29. S. D. Glick, D. A. Ross, and L. B. Hough, «Lateral Asymmetry of Neurotransmitters in Human Brain», Brain Research 234 (1982): 53–63; R. Carter, Mapping the Mind (London, UK: Phoenix Publishing, 2004); S. D. Glick, Cerebral Lateralization in Non-Human Species (Cambridge, MA: Academic Press, 1985); S. D. Glick, R. C. Meibach, R. D. Cox, and S. Maayani, «Multiple and Interrelated Functional Asymmetries in Rat Brain», Life Sciences 25 (1979): 395–400; S. L. Andersen and M. H. Teicher, «Sex Differences in Dopamine Receptors and Their Relevance to ADHD», Neuroscience & Biobehavioral Reviews 24 (2000): 137–141.

30. W. James, Principles of Psychology (New York: Henry Holt and Company, 1890).

31. E. Goldberg, The Wisdom Paradox: How Your Mind Can Grow Stronger as Your Brain Grows Older (New York: Gotham Books, 2005).

32. E. R. Kandel, In Search of Memory: The Emergence of a New Science of Mind (New York: W. W. Norton & Company, 2007).

33. W. Barr, E. Goldberg, J. Wasserstein, and P. Novelly, «Patterns of Retrograde Amnesia in Unilateral Temporal Lobectomies», Neuropsychologia 28 (1990): 243–255.

34. A. R. Luria, The Mind of a Mnemonist: A Little Book About a Vast Memory (Cambridge, MA: Harvard University Press, 1987).

35. J. L. McGaugh, «Making Lasting Memories: Remembering the Significant», Proceedings of the National Academy of Sciences USA 110 (2013): 10402—10407.

36. E. M. Hubbard and V. S. Ramachandran, «Neurocognitive Mechanisms of Synesthesia», Neuron 48 (2005): 509–520.

37. K. Vick, «Opiates of the Iranian People», Washington Post Foreign Service (September 23, 2005).

38. D. Martino, A. J. Espay, A. Fasano, and F. Morgante, Disorders of Movement: A Guide to Diagnosis and Treatment, 1st edn. (New York: Springer, 2016).

39. S. Varanese, B. Perfetti, S. Mason, A. Di Rocco, and E. Goldberg, «Lateralized Profiles of Frontal Lobe Dysfunction in Parkinson’s Disease», Presented at the Seventh International Congress on Mental Dysfunctions and Other Non-motor Features in Parkinson’s Disease and Related Disorders (Barcelona, Spain: 2010).

40. M. Jaffe, «Finding Equilibrium in Seesawing Libidos», New York Times (March 8, 2015): A6.

41. G. Giovannoni, J. D. O’Sullivan, K. Turner, A. J. Manson, and A. J. L. Lees, «Hedonistic Homeostatic Dysregulation in Patients with Parkinson’s Disease on Dopamine Replacement Therapies», Journal of Neurology, Neurosurgery, and Psychiatry 68 (2000): 423–428.

42. G. Giovannoni, J. D. O’Sullivan, K. Turner, A. J. Manson, and A. J. L. Lees, «Hedonistic Homeostatic Dysregulation in Patients with Parkinson’s Disease on Dopamine Replacement Therapies», Journal of Neurology, Neurosurgery, and Psychiatry 68 (2000): 423–428.

43. G. Rylander, «Psychoses and the Punding and Choreiform Syndromes in Addiction to Central Stimulant Drugs», Psychiatria, Neurologia, Neurochirurgia 75 (1972): 203–212; E. Schiorring, «Psychopathology Induced by ‘Speed Drugs’», Pharmacology, Biochemistry and Behavior 14 (1981): 109–122; N. A. Graham, C. J. Hammond, and M. S. Gold, «Drug-Induced Compulsive Behaviors: Exceptions to the Rule», Mayo Clinic Proceedings 84 (2009): 846–847.

44. P. Seeman, «Parkinson’s Disease Treatment May Cause Impulse-Control Disorder via Dopamine D3 Receptors», Synapse 69 (2015): 183–189; T. J. Moore, J. Glenmullen, and D. R. Mattison, «Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated with Dopamine Receptor Agonist Drugs», Journal of the American Medical Association: Internal Medicine 174 (2014): 1930–1933.

45. B. Levant, «The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance», Pharmacological Reviews 49 (1997): 231–252.